BridgeMD
New treatment option for Pediatric Asthma
Official title Cohort Multiple Randomized Controlled Trial in Pediatric Asthma
ClinicalTrials.gov ID: NCT06278662
What this study is testing
- What it's testing
- The overarching goal of this study is to optimize pediatric asthma care and to continuously evaluate variations/innovations of the care (including transformation to remote eHealth care). Primary Objectives within cmRCT cohort: Provide a framework for multiple randomized (eHealth) interventions for asthmatic children Generate short- and long-term data on Quality of life (QoL), asthma outcomes (asthma control, lung function), quality of care, self-management capacity, healthcare use, and therapy compliance in a representative secondary care pediatric asthma cohort.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 18
You may be able to join if
- Is 4 to 18 years old
- Is patient at the children's department at Medisch Spectrum Twente at moment of inclusion
- Is diagnosed with asthma by a pediatrician following the Global Initiative for Asthma(GINA) guidelines 2022 [8]: \ Medical history fitting asthma...
- Based on (typical) symptoms: (nighttime) wheezing, dyspnea, coughing (triggered by either viral infections, exercise, allergens or weather changes)
- (Possibly) supplemented with a family history/atopy AND \ Spirometry variable expiratory airflow limitation by at least one of these criteria:
You likely can't join if
- The child and/or parent(s) has/have insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer...
See the full eligibility criteria
- Is 4 to 18 years old
- Is patient at the children's department at Medisch Spectrum Twente at moment of inclusion
- Is diagnosed with asthma by a pediatrician following the Global Initiative for Asthma(GINA) guidelines 2022 [8]: \ Medical history fitting asthma diagnosis:
- Based on (typical) symptoms: (nighttime) wheezing, dyspnea, coughing (triggered by either viral infections, exercise, allergens or weather changes)
- (Possibly) supplemented with a family history/atopy AND \ Spirometry variable expiratory airflow limitation by at least one of these criteria:
- FEV1/FVC reduced compared to lower limit of normal(Z-score ≤ -1.64)
- Positive bronchodilator responsiveness(increase FEV1\>12%)
- Positive Exercise Challenge Test (ECT)(decrease FEV1≥ 13%)
- Excessive variation in lung function (LF) between tests from different dates (variation FEV1\>12% pred)
- The child and/or parent(s) has/have insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer questions
The study team makes the final eligibility decision.
Where it's taking place
- Enschede, Overijssel, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Enschede, Overijssel, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.